|
Market Closed -
Euronext Paris
19:55:00 21/08/2026 +04
|
After hours 23:59:48 | |||
| 72.84 EUR | +0.03% |
|
72.29 | -0.76% |
| 07-23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.76B | |||||
| 51.22B | |||||
| 45.38B | - | - | - | - | - |
| 41.97B | |||||
| 42.15B | |||||
| 31.95B |
- Stock Market
- Stocks
- ERF Stock
- Charts Eurofins Scientific SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
